1. Alter MJ, Culver DP, Baine WB, et al. Nationwide evaluation of effectiveness of targeted notification for HCV infection. Presented at: The Health and Human Services Advisory Committee on Blood Safety and Availability; January 27, 2000; Washington, DC.
2. Centers for Disease Control and Prevention. Hepatitis C. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/c/ edu/Intro/default.htm. Accessed June 19, 2000.
3. Guidance for industry: current good manufacturing practice for blood and blood components: (1) quarantine and disposition of units from prior collections from donors with repeatedly reactive screening test for antibody to hepatitis C virus (anti-HCV); (2) supplemental testing, and the notification of consignees and blood recipients of donor test results for anti-HCV. 63 Federal Register 56198-56199 (1998).
4. Centers for Disease Control and Prevention. Hepatitis C fact sheet. Available at: http://www.cdc.gov/ncidod/diseases/ hepatitis/c/fact.htm. Accessed June 29, 2000.
5. American Association of Blood Banks. Viral hepatitis. Available at: http://www.aabb.org/All_About_Blood/FAQs/ aabb_faqs.htm#viral. Aaccessed June 29, 2000.